Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
50.2 USD | +1.67% | -1.36% | +41.09% |
05-10 | Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing | MT |
05-09 | Crinetics Pharmaceuticals Q1 Net Loss Widens | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.09% | 3.89B | |
+26.33% | 49.18B | |
+0.27% | 42.11B | |
+50.18% | 40.37B | |
-5.26% | 28.85B | |
+12.47% | 26.09B | |
-21.74% | 18.71B | |
+8.69% | 13.26B | |
+31.68% | 12.32B | |
-0.58% | 11.99B |
- Stock Market
- Equities
- CRNX Stock
- News Crinetics Pharmaceuticals, Inc.
- Cantor Fitzgerald Adjusts Price Target on Crinetics Pharmaceuticals to $65 From $50, Maintains Overweight Rating